Skip to content

← All news

Markets

Milestone Pharmaceuticals begins phase 3 trial for AFib treatment

1 source ·1 article ·Aug 21, 12:04 UTC Milestone Pharmaceuticals

Covered by 1 outlet

All coverage · 1 article

Investing.com News ·Aug 21, 12:04 UTC

Milestone Pharmaceuticals begins phase 3 trial for AFib treatment